The “3-faced construct validation method” is a routine for establishing the validity and reliability of an existing scale when adapted in a different cultural context from the context initially developed. This routine can also be used for the initial validation of a newly developed scale. This is essentially a construct validation procedure based on a sample-splitting. The sample is randomly split into three parts, 20% for EFA, 40% for an exploratory CFA and 40% for a cross-validating CFA. The cases per variable threshold is set above 5:1, preferably above 10:1 (minimum conditions) and the first approximately 20% subsample emerges (adequate conditions) to evaluate EFA and Bifactor EFA models. Then the cases per variable threshold is set above 10:1, preferably above 20:1 (minimum conditions) and the 40% subsample emerges (adequate conditions) to examine alternative CFA models (ICM-CFA, Bifactor CFA, ESEM and Bifactor ESEM models). The optimal model(s) is cross-validated by a second CFA in yet another 40% subsample (equal-power CFA sample) as a protection against overfitting (over-optimization) to safeguard model replicability. Measurement invariance follows and is essentially another cross-check of the optimal model over the entire sample because the optimal model is used as the baseline model.
No takes yet. Share an insight, caveat, or question.
Theodoros Kyriazos (2018) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: